Literature DB >> 8496678

Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections.

M Stålhammar-Carlemalm1, L Stenberg, G Lindahl.   

Abstract

The group B Streptococcus, an important cause of invasive infections in the neonate, is classified into four major serotypes (Ia, Ib, II, and III) based on the structure of the polysaccharide capsule. Since the capsule is a known virulence factor, it has been extensively studied, in particular in type III strains, which cause the majority of invasive infections. Two cell surface proteins, alpha and beta, have also been studied in detail since they confer protective immunity, but these proteins are usually not expressed by type III strains. We describe here a cell surface protein, designated protein Rib (resistance to proteases, immunity, group B), that confers protective immunity and is expressed by most strains of type III. Protein Rib was first identified as a distinct 95-kD protein in extracts of a type III strain, and was purified to homogeneity from that strain. Rabbit antiserum to protein Rib was used to demonstrate that it is expressed on the cell surface of 31 out of 33 type III strains, but only on 1 out of 25 strains representing the other three serotypes. Mouse protection tests showed that antiserum to protein Rib protects against lethal infection with three different strains expressing this antigen, including a strain representing a recently identified high virulence type III clone. Protein Rib is immunologically unrelated to the alpha and beta proteins, but shares several features with the alpha protein. Most importantly, the NH2-terminal amino acid sequences of the Rib and alpha proteins are identical at 6 out of 12 positions. In addition, both protein Rib and the alpha protein are relatively resistant to trypsin (and Rib is also resistant to pepsin) and both proteins vary greatly in size between different clinical isolates. Finally, both protein Rib and the alpha protein exhibit a regular ladderlike pattern in immunoblotting experiments, which may reflect a repetitive structure. Taken together, these data suggest that the Rib and alpha proteins are members of a family of proteins with related structure and function. Since protein Rib confers protective immunity, it may be valuable for the development of a protein vaccine against the group B Streptococcus, an encapsulated bacterium.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8496678      PMCID: PMC2191029          DOI: 10.1084/jem.177.6.1593

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  Characterization of the alpha antigen of the c proteins of group B streptococci (GBS) using a murine monoclonal antibody.

Authors:  L Bevanger; O J Iversen; A I Naess
Journal:  APMIS       Date:  1992-01       Impact factor: 3.205

Review 2.  Group B streptococcal disease: its importance in the developing world and prospect for prevention with vaccines.

Authors:  J A Walsh; S Hutchins
Journal:  Pediatr Infect Dis J       Date:  1989-05       Impact factor: 2.129

3.  Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence.

Authors:  C E Rubens; M R Wessels; L M Heggen; D L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  The IgA-binding beta antigen of the c protein complex of Group B streptococci: sequence determination of its gene and detection of two binding regions.

Authors:  P G Jerlström; G S Chhatwal; K N Timmis
Journal:  Mol Microbiol       Date:  1991-04       Impact factor: 3.501

5.  Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.

Authors:  M R Wessels; L C Paoletti; D L Kasper; J L DiFabio; F Michon; K Holme; H J Jennings
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

6.  A monoclonal antibody identifies a protective C-protein alpha-antigen epitope in group B streptococci.

Authors:  L C Madoff; J L Michel; D L Kasper
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

7.  Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease.

Authors:  J M Musser; S J Mattingly; R Quentin; A Goudeau; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

8.  Two major classes in the M protein family in group A streptococci.

Authors:  P W O'Toole; P O'Toole; L Stenberg; M Rissler; G Lindahl
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

9.  Type-specific antigens of group B type Ic streptococci.

Authors:  H W Wilkinson; R G Eagon
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

10.  Mouse-protective effect of rabbit anti-R-protein antibodies against group B streptococci type II carrying R-protein. Lack of effect on type III carrying R-protein.

Authors:  V Lindén
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1983-04
View more
  89 in total

1.  Mosaicism in the alpha-like protein genes of group B streptococci.

Authors:  C S Lachenauer; R Creti; J L Michel; L C Madoff
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

2.  Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.

Authors:  C Gravekamp; D L Kasper; L C Paoletti; L C Madoff
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  High expression of a C protein beta antigen gene among invasive strains from certain clonally related groups of type Ia and Ib group B streptococci.

Authors:  Noriyuki Nagano; Yukiko Nagano; Fumiaki Taguchi
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

4.  Localization of surface immunogenic protein on group B streptococcus.

Authors:  S Rioux; D Martin; H W Ackermann; J Dumont; J Hamel; B R Brodeur
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

5.  Tandem repeat deletion in the alpha C protein of group B streptococcus is recA independent.

Authors:  K M Puopolo; S K Hollingshead; V J Carey; L C Madoff
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

6.  Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.

Authors:  Ravin Seepersaud; Sean B Hanniffy; Peter Mayne; Phil Sizer; Richard Le Page; Jerry M Wells
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

7.  Immunological markers of the R4 protein of Streptococcus agalactiae.

Authors:  Johan A Maeland; Lars Bevanger; Randi Valsoe Lyng
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

8.  Identification of a Streptococcus agalactiae serotype III subtype 4 clone in association with adult invasive disease in Hong Kong.

Authors:  Margaret Ip; Edmund S C Cheuk; Michelle H Y Tsui; Fanrong Kong; T N Leung; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

9.  Recombinant group B streptococcus Beta C protein and a variant with the deletion of its immunoglobulin A-binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccines.

Authors:  Hsiao-Hui Yang; Lawrence C Madoff; Hilde-Kari Guttormsen; Yong-Dong Liu; Lawrence C Paoletti
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

10.  Invasive group B streptococcus (GBS) disease in Norway 1996-2006.

Authors:  H Bergseng; M Rygg; L Bevanger; K Bergh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-17       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.